Literature DB >> 12372820

Autocrine activation of the hepatocyte growth factor receptor/met tyrosine kinase induces tumor cell motility by regulating pseudopodial protrusion.

Julie Vadnais1, Geneviève Nault, Zeinab Daher, Mohammad Amraei, Yolaine Dodier, Ivan Robert Nabi, Josette Noël.   

Abstract

The multiple beta-actin rich pseudopodial protrusions of the invasive variant of Moloney sarcoma virus (MSV)-transformed epithelial MDCK cells (MSV-MDCK-INV) are strongly labeled for phosphotyrosine. Increased tyrosine phosphorylation among a number of proteins was detected in MSV-MDCK-INV cells relative to untransformed and MSV-transformed MDCK cells, especially for the hepatocyte growth factor receptor (HGF-R), otherwise known as c-met proto-oncogene. Cell surface expression of HGF-R was similar in the three cell lines, indicating that HGF-R is constitutively phosphorylated in MSV-MDCK-INV cells. Both the tyrosine kinase inhibitor herbimycin A and the HGFalpha antibody abolished HGF-R phosphorylation, induced retraction of pseudopodial protrusions, and promoted the establishment of cell-cell contacts as well as the apparition of numerous stabilizing stress fibers in MSV-MDCK-INV cells. Furthermore, anti-HGFalpha antibody abolished cell motility among MSV-MDCK-INV cells. Conditioned medium from MSV-MDCK-INV cells induced MDCK cell scattering, indicating that HGF is secreted by MSV-MDCK-INV cells. HGF titration followed by a subsequent washout of the antibodies led to renewed pseudopodial protrusion and cellular movement. We therefore show that activation of the tyrosine kinase activity of HGF-R/Met via an autocrine HGF loop is directly responsible for pseudopodial protrusion, thereby explaining the motile and invasive potential of this model epithelium-derived tumor cell line.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12372820     DOI: 10.1074/jbc.M209481200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  8 in total

1.  An overview of the c-MET signaling pathway.

Authors:  Shawna Leslie Organ; Ming-Sound Tsao
Journal:  Ther Adv Med Oncol       Date:  2011-11       Impact factor: 8.168

2.  Localized Rho GTPase activation regulates RNA dynamics and compartmentalization in tumor cell protrusions.

Authors:  Heather C Stuart; Zongjian Jia; Anat Messenberg; Bharat Joshi; T Michael Underhill; Hakima Moukhles; Ivan R Nabi
Journal:  J Biol Chem       Date:  2008-10-09       Impact factor: 5.157

3.  Protein phosphatase-2A maintains focal adhesion complexes in keratinocytes and the loss of this regulation in squamous cell carcinomas.

Authors:  Alex A Romashko; M Rita I Young
Journal:  Clin Exp Metastasis       Date:  2004       Impact factor: 5.150

Review 4.  The hepatocyte growth factor/c-Met signaling pathway as a therapeutic target to inhibit angiogenesis.

Authors:  Weon-Kyoo You; Donald M McDonald
Journal:  BMB Rep       Date:  2008-12-31       Impact factor: 4.778

5.  Insulin-sensitizing and anti-proliferative effects of Argania spinosa seed extracts.

Authors:  Samira Samane; Josette Noël; Zoubida Charrouf; Hamid Amarouch; Pierre Selim Haddad
Journal:  Evid Based Complement Alternat Med       Date:  2006-04-11       Impact factor: 2.629

Review 6.  Involvement of Membrane Blebbing in Immunological Disorders and Cancer.

Authors:  Maitham A Khajah; Yunus A Luqmani
Journal:  Med Princ Pract       Date:  2015-11-26       Impact factor: 1.927

Review 7.  Hepatocyte Growth Factor/c-Met Signaling in Head and Neck Cancer and Implications for Treatment.

Authors:  Natalie J Rothenberger; Laura P Stabile
Journal:  Cancers (Basel)       Date:  2017-04-24       Impact factor: 6.639

8.  Stable Ectopic Expression of ST6GALNAC5 Induces Autocrine MET Activation and Anchorage-Independence in MDCK Cells.

Authors:  Chia Chu; Donald P Bottaro; Michael J Betenbaugh; Joseph Shiloach
Journal:  PLoS One       Date:  2016-02-05       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.